{"version":"1.0","type":"link","title":"Pharmacogenomics of Sorafenib in Hepatocellular Carcinoma (HCC): A LncRNA-Expression Guided Approach Using UCA1 and MALAT1 for Personalizing Therapy in a 154-Patient Cohort.","author_name":"Nazih M 외","author_url":"https://prs-insight.online/author/Nazih%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/112951","thumbnail_width":1200,"thumbnail_height":630}